Loading clinical trials...
Loading clinical trials...
A Phase 1/2a Randomized, Double-masked, Placebo Controlled, Dose-ranging Study of the Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension
Conditions
Interventions
H-1337 Placebo
H-1337 [1]
+2 more
Locations
1
United States
PRN
Goose Creek, South Carolina, United States
Start Date
March 15, 2018
Primary Completion Date
August 15, 2018
Completion Date
August 15, 2018
Last Updated
July 12, 2022
NCT05885022
NCT06201455
NCT05624398
NCT05325996
NCT05044793
NCT03868124
Lead Sponsor
Allysta Pharmaceutical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions